(Parsippany, NJ, Thursday, June 09, 2016) – Bioceutics, a specialized marketing, education and communications division of Diaceutics, the leading provider of personalized medicine integration services, and TBWA\WorldHealth, the leading healthcare communications company, has won first place at the 2016 Diagnostic Marketing Association (DxMA) Awards in the Other Healthcare Campaign category, for work to support their pharma client’s rebranding to signal leadership in driving precision medicine. The annual awards reception honors the “best of the best” in diagnostics marketing, advertising and promotional programming.
“We are delighted to receive this award from the DxMA,” said Sanna Jousi, Managing Director of Bioceutics. “Our teams put a lot of hard work and creativity into this campaign and winning first place is excellent recognition from the industry.”
Bioceutics helped their client define the company’s vision and establish a clear and compelling brand identity for use within the family of companies and among external stakeholders. The work was grounded in a refreshed strategic direction that informed a series of rebranding efforts, including messaging, that spanned both online and offline tactics.
“This was a particularly interesting challenge; rebranding an already recognized leader in the diagnostic space,” said Paul Pfleiderer, PhD, Managing Director of Bioceutics and Chief Strategy Officer at TBWA\WorldHealth. “The client’s commitment and passion in precision medicine was a big inspirational driver for our work. They were terrific partners in the process and we are pleased to share this award with them.”
Central to these rebranding efforts was a refreshed look and feel that was infused into all new materials associated with the company. Additional online materials included a publically available video asset describing the value of precision medicine and leadership efforts in this space.
Diaceutics is transforming an industry model by enabling pharmaceutical companies to accelerate their market penetration and achieve a better return on new drugs by helping them to radically improve their patient testing. It does this by allowing them access to real-time testing data from its worldwide laboratory network, which helps them understand and leverage the diagnostic landscape and segment physicians by their testing behavior. The company leads the top 10 global markets in its cancer-related therapy area, with a 60% market share and experience of more than 200 drug launches. Eight out of the world’s top 10 pharmaceutical companies are clients and it currently analyses 80% of testing data in the US in its selected cancer related therapy areas. The company employs the leading global group of experts from the laboratory, diagnostic and pharmaceutical industries.
TBWA\WorldHealth, a global healthcare communications agency, leverages the power of disruption and media arts to create behavior-changing ideas. For more information, visit www.tbwaworldhealth.com.